Stellular Bio
Latest round
- Series B
Last raised
- Oct 2021
Total raised
- $72M
Investors
- 9
About Stellular Bio
, operates as a biotechnology company that provides platelet-derived regenerative biologic therapies for ocular surface disease.
Who invested in Stellular Bio
9 investors across 3 rounds
See all investors in Stellular Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Stellular Bio
Who invested in Stellular Bio?
Stellular Bio has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Stellular Bio raised?
Stellular Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Stellular Bio last raise money?
Stellular Bio's most recent round on record is a Series B, in Oct 2021.
What does Stellular Bio do?
, operates as a biotechnology company that provides platelet-derived regenerative biologic therapies for ocular surface disease.
Where is Stellular Bio headquartered?
Stellular Bio is headquartered in Watertown, US.
Which VCs invest in companies like Stellular Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Stellular Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Stellular Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.